- Companies
- New Frontier Health
New Frontier Health Valuation, Funding & Investors
New Frontier Health is valued at $1.9B as of March 2025.
Last New Frontier Health valuation
$1.9B
Secondary · Mar 2025
Key investors in New Frontier Health
Warburg Pincus
New Frontier Health Overview
About New Frontier Health
New Frontier Health is an operator of private hospitals and clinics delivering premium medical services in China. Shanghai-headquartered, it manages facilities in Beijing and Guangzhou specializing in cardiology, oncology, orthopedics, and maternity care with international-standard equipment. The network integrates telemedicine and executive health checkups for expatriates and high-net-worth individuals.
Founded
1981
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Valuation
$1.9B (Mar 2025)
Sectors
New Frontier Health Valuation
New Frontier Health is currently valued at $1.9B, based on its secondary sale in March 2025. Read the announcement ↗
The $124M round was led by Warburg Pincus.
New Frontier Health valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Mar 2025 | Secondary | $1.9B |
New Frontier Health Funding History
New Frontier Health has 1 recorded secondary share sale and no primary funding rounds.
New Frontier Health funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Mar 2025 | Secondary | Warburg Pincus (lead) | $124M | $1.9B | Warburg Pincus acquired a 6.6% stake in New Frontier Health from Fosun Pharmaceutical for $124.08 million in March 2025. This transaction represented a follow-on investment by Warburg Pincus, which was already an investor in the company. New Frontier Health operates a network of healthcare facilities in China under the United Family Healthcare brand, including 11 hospitals and 24 clinics. The company was previously taken private in January 2022 through a consortium acquisition led by Fosun Pharmaceutical, Goldman Sachs Asset Management, Vivo Capital, and Warburg Pincus at a valuation of $4.78 billion. The company's business encompasses comprehensive hospitals, rehabilitation healthcare, home healthcare, insurance services, medical technology, and medical real estate, serving both institutional and individual healthcare needs across China. The transaction allowed Fosun Pharma to exit its position and concentrate resources on its core pharmaceutical operations. |
Who has invested in New Frontier Health?
1 investor has backed New Frontier Health across its funding rounds, including Warburg Pincus.
Lead investors include Warburg Pincus.
New Frontier Health Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
This data is available for Pro users. Sign up to see all 1 New Frontier Health investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialInvestments by New Frontier Health
New Frontier Health has invested in 1 company to date.
Latest investment by New Frontier Health was on November 29th 2021. New Frontier Health invested in Abogen Biosciences in their $300M Series C round.
Latest Investments by New Frontier Health
| Description | Abogen Biosciences is a Vancouver-based biotechnology firm developing nucleic acid therapeutics targeting cancer and infectious diseases. Its pipeline includes RNA and DNA-based candidates in preclinical stages for oncology and antivirals. Founded in 2015, the company collaborates with academic institutions in British Columbia on gene silencing technologies. |
| HQ Country | |
| HQ City | Suzhou |
| Deal Date | 29 Nov 2021 |
| Round | Series C |
| Raised | $300M |
| Investors | Mirae Asset; SoftBank Group; DNE Capital Management; Fortune Ocean Growth Fund; Innolink Fund; Jinyi Capital; Keyuan Industry Fund; 5Y Capital; Linden Asset; Chimera Investment; IMO Ventures |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all New Frontier Health investments and their VC round multiples. Start Free Trial | |
New Frontier Health Competitors
New Frontier Health competitors include listed companies like Huaxia Eye Hospital Group, Fakeeh Care Group, Draegerwerk and Astrana Health, and private ones like Fosun Health and Shulan Health.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $622M | $143M | $1.9B | 2.2x | ||
| Publicly listed | $824M | $131M | $1.9B | 2.5x | ||
| Publicly listed | $3.9B | $436M | $1.8B | 0.5x | ||
| Publicly listed | $3.2B | $123M | $1.8B | 0.6x | ||
| Private | $913M | - | $1.5B | 1.6x | ||
| Private | - | - | $1.2B | - |
New Frontier Health Public Comps
New Frontier Health is still privately-owned, but its public comps include Huaxia Eye Hospital Group, Fakeeh Care Group, Draegerwerk, Astrana Health, Dallah Healthcare, AMN Healthcare Services, Dr Agarwals, Ardent Health, Burjeel Holdings and Aevis Victoria.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $622M | $143M | 2.4x | 2.2x | 10.3x | 10.1x | |||
| $824M | $131M | 2.7x | 2.5x | 16.8x | 15.8x | |||
| $3.9B | $436M | 0.5x | 0.5x | 4.6x | 4.6x | |||
| $3.2B | $123M | 0.7x | 0.6x | 17.5x | 8.3x | |||
| $1.1B | $246M | 2.9x | 2.7x | 12.8x | 12.4x | |||
| $2.7B | $101M | 0.8x | 0.7x | 22.1x | 7.2x | |||
| $219M | $64M | 8.2x | 7.2x | 28.2x | 27.0x | |||
| $6.3B | $497M | 0.6x | 0.6x | 7.3x | 7.2x | |||
This data is available for Pro users. Sign up to see all New Frontier Health competitors and their valuation data. Start Free Trial | ||||||||
Common questions about New Frontier Health
| When was New Frontier Health founded? | New Frontier Health was founded in 1981. |
| Where is New Frontier Health headquartered? | New Frontier Health is headquartered in Hong Kong, Hong Kong. |
| Is New Frontier Health publicly listed? | No, New Frontier Health is a private, VC-backed company. |
| What is New Frontier Health's valuation? | New Frontier Health was last valued at $1.9B in its secondary sale in March 2025. |
| Who are New Frontier Health's investors? | New Frontier Health's investors include Warburg Pincus. |
| Which companies are comparable to New Frontier Health? | Companies comparable to New Frontier Health include Huaxia Eye Hospital Group, Fakeeh Care Group, Draegerwerk, Astrana Health, Fosun Health and Shulan Health. |
| How many companies has New Frontier Health invested in? | New Frontier Health has invested in 1 company, including Abogen Biosciences. |
| What was New Frontier Health's last investment? | In November 2021, New Frontier Health invested in Abogen Biosciences' $300M Series C alongside Mirae Asset, SoftBank Group, DNE Capital Management and 8 other investors. |
See companies similar to New Frontier Health
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




